Pure Global

Effect of Galacto-oligosaccharides (GOS) on Faecal Gut Microbiota in Adult Women - Trial NCT05762965

Access comprehensive clinical trial information for NCT05762965 through Pure Global AI's free database. This phase not specified trial is sponsored by Wageningen University and Research and is currently Recruiting. The study focuses on Microbial Colonization. Target enrollment is 92 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05762965
Recruiting
dietary supplement
Trial Details
ClinicalTrials.gov โ€ข NCT05762965
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Effect of Galacto-oligosaccharides (GOS) on Faecal Gut Microbiota in Adult Women

Study Focus

Microbial Colonization

GOS 1

Interventional

dietary supplement

Sponsor & Location

Wageningen University and Research

Wageningen, Netherlands

Timeline & Enrollment

N/A

May 15, 2023

Jul 08, 2023

92 participants

Primary Outcome

faecal abundance of Bifidobacterium,faecal abundance of Bifidobacterium,faecal abundance of Bifidobacterium

Summary

Within the Denali study the effect of 3 weeks intervention with GOS on the abundance of
 Bifidobacterium in faecal samples will be investigated.

ICD-10 Classifications

Bacterial infection of unspecified site
Other bacterial infections of unspecified site
Bacterial, viral and other infectious agents
Cholera
Other specified bacterial intestinal infections

Data Source

ClinicalTrials.gov

NCT05762965

Non-Device Trial